title: Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
authors.forename: F
authors.initials: F
authors.lastname: Du
authors.forename: P
authors.initials: P
authors.lastname: Yuan
authors.forename: Z T
authors.initials: ZT
authors.lastname: Zhao
authors.forename: Z
authors.initials: Z
authors.lastname: Yang
authors.forename: T
authors.initials: T
authors.lastname: Wang
authors.forename: J D
authors.initials: JD
authors.lastname: Zhao
authors.forename: Y
authors.initials: Y
authors.lastname: Luo
authors.forename: F
authors.initials: F
authors.lastname: Ma
authors.forename: J Y
authors.initials: JY
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Fan
authors.forename: R G
authors.initials: RG
authors.lastname: Cai
authors.forename: P
authors.initials: P
authors.lastname: Zhang
authors.forename: Q
authors.initials: Q
authors.lastname: Li
authors.forename: Y M
authors.initials: YM
authors.lastname: Song
authors.forename: B H
authors.initials: BH
authors.lastname: Xu